chr7:99354583:> Detail (hg19)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr7:99,354,583-99,381,871 |
| hg38 | chr7:99,756,960-99,784,248 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
| Score | Disease name | Description | Source | Pubmed | Links |
|---|---|---|---|---|---|
| 0.002 | squamous cell carcinoma | NA | GAD | Detail | |
| 0.002 | Neoplastic Cell Transformation | NA | GAD | Detail | |
| <0.001 | cerebral infarction | NA | BeFree | Detail | |
| <0.001 | Primary biliary cirrhosis | NA | BeFree | Detail | |
| <0.001 | cholestasis | NA | BeFree | Detail | |
| 0.003 | ulcerative colitis | NA | BeFree,GAD | Detail | |
| <0.001 | colorectal carcinoma | NA | BeFree | Detail | |
| 0.005 | Colorectal Neoplasms | NA | GAD | Detail | |
| 0.001 | Coronary Arteriosclerosis | NA | BeFree | Detail | |
| 0.001 | Coronary heart disease | NA | BeFree | Detail | |
| <0.001 | Crohn Disease | NA | BeFree | Detail | |
| <0.001 | cystic fibrosis | NA | BeFree | Detail | |
| <0.001 | Delirium | NA | BeFree | Detail | |
| <0.001 | Diabetes | NA | BeFree | Detail | |
| 0.006 | diabetes mellitus | NA | BeFree,GAD | Detail | |
| 0.093 | Diabetes Mellitus, Non-Insulin-Dependent | In conclusion, we have described for the first time a significant correlation of... | BeFree,CTD_rat,GAD,LHGDN | 24996290 | Detail |
| 0.003 | diarrhea | NA | BeFree,GAD | Detail | |
| 0.002 | drug allergy | NA | GAD | Detail | |
| 0.003 | Endometrial Neoplasms | NA | LHGDN | Detail | |
| 0.003 | epilepsy | NA | BeFree,GAD | Detail | |
| 0.005 | Esophageal Neoplasms | NA | GAD | Detail | |
| 0.002 | Exanthema | NA | GAD | Detail | |
| <0.001 | Fatty Liver | NA | BeFree | Detail | |
| 0.002 | Femur Head Necrosis | NA | GAD | Detail | |
| <0.001 | gastroesophageal reflux disease | NA | BeFree | Detail | |
| 0.007 | Head and Neck Neoplasms | NA | GAD | Detail | |
| <0.001 | hepatitis B | NA | BeFree | Detail | |
| 0.121 | hepatitis C | NA | BeFree,CTD_human | Detail | |
| 0.002 | heroin dependence | NA | GAD | Detail | |
| 0.029 | HIV Infections | CYP3A4*22 (c.522-191 C>T; rs35599367) is associated with lopinavir pharmacokinet... | BeFree,GAD | 24950369 | Detail |
| 0.029 | HIV Infections | CYP3A4 polymorphism and lopinavir toxicity in an HIV-infected pregnant woman. | BeFree,GAD | 25391550 | Detail |
| 0.029 | HIV Infections | We evaluated EFV400 and EFV600 pharmacokinetics (NONMEM v. 7.2), assessing patie... | BeFree,GAD | 26044067 | Detail |
| 0.008 | Hypercholesterolemia | NA | BeFree,GAD | Detail | |
| 0.005 | Hyperlipidemia | Polymorphism of CYP3A4 2 and eNOS genes in the diabetic patients with hyperlipid... | BeFree,GAD | 24996290 | Detail |
| 0.001 | hyperlipoproteinemia type III | NA | BeFree | Detail | |
| 0.008 | Hypertensive disease | NA | BeFree,GAD | Detail | |
| 0.002 | Hypopharyngeal Neoplasms | NA | GAD | Detail | |
| 0.080 | Inflammation | NA | CTD_rat | Detail | |
| <0.001 | Inflammatory Bowel Diseases | In the present study, the effects of artemisinin on pregnane X receptor (PXR)-me... | BeFree | 24886881 | Detail |
| 0.002 | Kidney Diseases | NA | GAD | Detail | |
| 0.003 | Kidney Failure, Acute | NA | BeFree,GAD | Detail | |
| 0.081 | Kidney Failure, Chronic | NA | BeFree,RGD | Detail | |
| 0.002 | Kidney Neoplasm | NA | GAD | Detail | |
| 0.007 | Laryngeal neoplasm | NA | GAD | Detail | |
| 0.010 | leukemia | NA | BeFree,GAD | Detail | |
| 0.002 | lymphoid leukemia | NA | GAD | Detail | |
| 0.002 | Acute lymphocytic leukemia | We genotyped eight common single-nucleotide polymorphisms (SNPs) in the CYP3A4 a... | BeFree | 25266680 | Detail |
| <0.001 | Leukemia, Lymphocytic, Acute, L1 | In interaction with gender a common CYP3A4 polymorphism may influence the surviv... | BeFree | 25266680 | Detail |
| 0.001 | Leukemia, Myelocytic, Acute | NA | BeFree | Detail | |
| <0.001 | Myeloid Leukemia, Chronic | NA | BeFree | Detail | |
| 0.003 | leukopenia | NA | BeFree,GAD | Detail | |
| 0.004 | liver cirrhosis | NA | BeFree,LHGDN | Detail | |
| 0.010 | Liver diseases | NA | BeFree,GAD,LHGDN | Detail | |
| 0.002 | Liver neoplasms | Establishment of cytochrome P450 3A4 and glutathione S-transferase A1-transfecte... | BeFree | 24782212 | Detail |
| 0.005 | Lung Neoplasms | NA | BeFree,GAD,LHGDN | Detail | |
| 0.002 | lupus nephritis | NA | GAD | Detail | |
| <0.001 | lymphoma | NA | BeFree | Detail | |
| 0.002 | malaria | NA | GAD | Detail | |
| <0.001 | Primary malignant neoplasm of liver | NA | BeFree | Detail | |
| 0.002 | Animal Mammary Neoplasms | NA | GAD | Detail | |
| <0.001 | Mesothelioma | NA | BeFree | Detail | |
| <0.001 | Metabolic Diseases | When compared with the wild-type genotype, the variant genotypes rs5767743 and r... | BeFree | 26334901 | Detail |
| 0.005 | Mouth Neoplasms | NA | GAD | Detail | |
| 0.004 | myopathy | Aim of this review is: (i) to describe the molecular mechanisms associated to st... | BeFree,GAD | 24835295 | Detail |
| 0.003 | myocardial infarction | No association between CYP3A4*22 and statin effectiveness in reducing the risk f... | BeFree,GAD | 25303298 | Detail |
| 0.003 | Neoplasm Metastasis | NA | BeFree,GAD | Detail | |
| 0.005 | Neoplasms, Germ Cell and Embryonal | NA | GAD | Detail | |
| <0.001 | nephrotic syndrome | NA | BeFree | Detail | |
| <0.001 | neuroblastoma | Association of CYP3A4/5 genotypes and expression with the survival of patients w... | BeFree | 25370902 | Detail |
| 0.007 | neutropenia | NA | BeFree,GAD | Detail | |
| <0.001 | obesity | In the small intestine and colon, no changes of CYP enzymes were detected except... | BeFree | 25998026 | Detail |
| 0.002 | Bone necrosis | NA | GAD | Detail | |
| 0.006 | osteoporosis | NA | BeFree,GAD,LHGDN | Detail | |
| 0.123 | osteosarcoma | NA | CTD_human,LHGDN | Detail | |
| <0.001 | ovarian carcinoma | NA | BeFree | Detail | |
| <0.001 | Pain, Postoperative | NA | BeFree | Detail | |
| <0.001 | Peripheral neuropathy | NA | BeFree | Detail | |
| 0.005 | Pharyngeal Neoplasms | NA | GAD | Detail | |
| 0.123 | Prostatic Neoplasms | NA | BeFree,CTD_human,LHGDN | Detail | |
| 0.006 | schizophrenia | Both aripiprazole and haloperidol have been used in the treatment of schizophren... | BeFree,GAD | 24739668 | Detail |
| 0.002 | Skin Neoplasms | NA | GAD | Detail | |
| <0.001 | Cerebrovascular accident | NA | BeFree | Detail | |
| <0.001 | Subarachnoid Hemorrhage | NA | BeFree | Detail | |
| 0.002 | Testicular Neoplasms | NA | GAD | Detail | |
| 0.003 | thalassemia | NA | LHGDN | Detail | |
| <0.001 | Thromboembolism | Phenprocoumon is an anticoagulant used for thromboembolic disorder prophylaxis m... | BeFree | 25461249 | Detail |
| 0.120 | Torsades de pointes | NA | CTD_human | Detail | |
| <0.001 | tuberculosis | NA | BeFree | Detail | |
| 0.002 | Genitourinary Neoplasms | NA | GAD | Detail | |
| <0.001 | Viremia | NA | BeFree | Detail | |
| 0.002 | Lymphoma, T-Cell, Cutaneous | NA | GAD | Detail | |
| 0.003 | peripheral T-cell lymphoma | NA | BeFree,GAD | Detail | |
| 0.002 | Ovarian Failure, Premature | NA | GAD | Detail | |
| <0.001 | Alcohol abuse | NA | BeFree | Detail | |
| <0.001 | Depressive Symptoms | NA | BeFree | Detail | |
| <0.001 | Small cell carcinoma of lung | NA | BeFree | Detail | |
| 0.002 | Migraine Disorders | NA | GAD | Detail | |
| <0.001 | Myocardial Ischemia | NA | BeFree | Detail | |
| <0.001 | Hepatic necrosis | NA | BeFree | Detail | |
| 0.003 | lingual-facial-buccal dyskinesia | NA | BeFree,GAD | Detail | |
| 0.002 | Malignant neoplasm of mouth | NA | GAD | Detail | |
| 0.007 | Malignant neoplasm of testis | NA | GAD | Detail | |
| 0.003 | Liver Failure, Acute | NA | BeFree,GAD | Detail | |
| <0.001 | hepatoblastoma | NA | BeFree | Detail | |
| 0.002 | Squamous Cell Neoplasms | NA | GAD | Detail | |
| <0.001 | gliosarcoma | NA | BeFree | Detail | |
| <0.001 | Chronic schizophrenia | NA | BeFree | Detail | |
| <0.001 | Xanthomatosis, Cerebrotendinous | NA | BeFree | Detail | |
| 0.003 | Gastrointestinal Stromal Tumors | NA | BeFree,GAD | Detail | |
| <0.001 | Hepatitis, Autoimmune | NA | BeFree | Detail | |
| 0.002 | Dyslipidemias | NA | GAD | Detail | |
| 0.016 | Malignant neoplasm of lung | NA | BeFree,GAD | Detail | |
| <0.001 | Somatotropin deficiency | NA | BeFree | Detail | |
| 0.002 | cervix carcinoma | NA | GAD | Detail | |
| <0.001 | Adenocarcinoma of colon | NA | BeFree | Detail | |
| <0.001 | Chronic liver disease | NA | BeFree | Detail | |
| <0.001 | Primary hypercholesterolemia | No effect of CYP3A4 intron 6 C>T polymorphism (CYP3A4*22) on lipid-lowering resp... | BeFree | 25274942 | Detail |
| <0.001 | Absence of pain sensation | NA | BeFree | Detail | |
| 0.005 | Malignant neoplasm of liver | NA | GAD | Detail | |
| <0.001 | Infusion related reaction | Two SNPs associated with docetaxel toxicity were identified: CYP3A4*1B with infu... | BeFree | 25495407 | Detail |
| 0.051 | Malignant neoplasm of prostate | Levels of enzymes that determine testosterone catabolism such as CYP3A4 have bee... | BeFree,GAD | 24924803 | Detail |
| 0.051 | Malignant neoplasm of prostate | Association between cytochrome CYP17A1, CYP3A4, and CYP3A43 polymorphisms and pr... | BeFree,GAD | 25337833 | Detail |
| <0.001 | Non-alcoholic Fatty Liver Disease | NA | BeFree | Detail | |
| <0.001 | Osteomalacia secondary to drug | NA | BeFree | Detail | |
| <0.001 | neuropathy | Whole-exome sequencing reveals defective CYP3A4 variants predictive of paclitaxe... | BeFree | 25398452 | Detail |
| <0.001 | endometrial carcinoma | NA | BeFree | Detail | |
| 0.003 | Metabolic syndrome X | NA | BeFree,GAD | Detail | |
| <0.001 | Hepatitis C, Chronic | NA | BeFree | Detail | |
| 0.002 | Malignant neoplasm of esophagus | NA | GAD | Detail | |
| 0.002 | Thyroid carcinoma | NA | GAD | Detail | |
| <0.001 | Lower Urinary Tract Symptoms | NA | BeFree | Detail | |
| 0.004 | breast carcinoma | In multivariate analyses, we observed a significantly decreased risk of breast c... | BeFree | 19214745 | Detail |
| 0.050 | Malignant neoplasm of breast | In multivariate analyses, we observed a significantly decreased risk of breast c... | BeFree | 19214745 | Detail |
| 0.003 | Carcinogenesis | NA | BeFree | Detail | |
| <0.001 | Leukemogenesis | NA | BeFree | Detail | |
| 0.008 | prostate carcinoma | Levels of enzymes that determine testosterone catabolism such as CYP3A4 have bee... | BeFree | 24924803 | Detail |
| 0.008 | prostate carcinoma | Association between cytochrome CYP17A1, CYP3A4, and CYP3A43 polymorphisms and pr... | BeFree | 25337833 | Detail |
| 0.003 | Hot flushes | Tamoxifen-associated hot flash severity is inversely correlated with endoxifen c... | BeFree,GAD | 24744093 | Detail |
| 0.002 | Epithelial ovarian cancer | NA | GAD | Detail | |
| 0.004 | breast carcinoma | The purpose of this study was to investigate the role of single nucleotide polym... | BeFree | 25410489 | Detail |
| 0.001 | Carcinoma of lung | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of gastrointestinal tract | NA | BeFree | Detail | |
| 0.003 | Tardive Dyskinesia | NA | BeFree,GAD | Detail | |
| <0.001 | Secondary malignant neoplasm of lymph node | NA | BeFree | Detail | |
| 0.001 | colon carcinoma | NA | BeFree | Detail | |
| <0.001 | Carcinoma of bladder | NA | BeFree | Detail | |
| <0.001 | Central neuroblastoma | Association of CYP3A4/5 genotypes and expression with the survival of patients w... | BeFree | 25370902 | Detail |
| 0.002 | Helicobacter pylori infection | NA | GAD | Detail | |
| <0.001 | 21-hydroxylase deficiency | NA | BeFree | Detail | |
| <0.001 | Enzyme inhibition disorder | NA | BeFree | Detail | |
| <0.001 | Advanced cancer | NA | BeFree | Detail | |
| <0.001 | Diffuse panbronchiolitis | NA | BeFree | Detail | |
| 0.010 | ovarian neoplasm | NA | GAD,LHGDN | Detail | |
| 0.010 | Acute coronary syndrome | NA | BeFree,GAD | Detail | |
| <0.001 | Colorectal cancer metastatic | NA | BeFree | Detail | |
| 0.007 | Malignant neoplasm of ovary | NA | BeFree,GAD | Detail | |
| <0.001 | Congenital long QT syndrome | NA | BeFree | Detail | |
| <0.001 | sarcoma | NA | BeFree | Detail | |
| <0.001 | Advanced cirrhosis | NA | BeFree | Detail | |
| <0.001 | Adenocarcinoma of large intestine | NA | BeFree | Detail | |
| 0.134 | Mammary Neoplasms | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
| <0.001 | Hepatocarcinogenesis | NA | BeFree | Detail | |
| 0.008 | colorectal cancer | NA | BeFree,GAD | Detail | |
| 0.002 | Renal Insufficiency | NA | GAD | Detail | |
| 0.002 | Delayed Graft Function | NA | GAD | Detail | |
| 0.001 | Cirrhosis | NA | BeFree | Detail | |
| 0.001 | Benign Prostatic Hyperplasia | NA | BeFree | Detail | |
| <0.001 | uterine corpus cancer | NA | BeFree | Detail | |
| 0.007 | coronary artery disease | NA | GAD | Detail | |
| <0.001 | Transformed migraine | NA | BeFree | Detail | |
| 0.004 | Precursor Cell Lymphoblastic Leukemia Lymphoma | We genotyped eight common single-nucleotide polymorphisms (SNPs) in the CYP3A4 a... | BeFree,GAD | 25266680 | Detail |
| 0.007 | liver carcinoma | Establishment of cytochrome P450 3A4 and glutathione S-transferase A1-transfecte... | BeFree,LHGDN | 24782212 | Detail |
| <0.001 | Lipoprotein glomerulopathy | NA | BeFree | Detail | |
| <0.001 | Steatohepatitis | NA | BeFree | Detail | |
| 0.003 | Treatment related leukaemia | NA | BeFree,GAD | Detail | |
| <0.001 | Congenital adrenal hyperplasia due to 21 hydroxylase deficiency | NA | BeFree | Detail | |
| 0.002 | Prostatic Hyperplasia | NA | GAD | Detail | |
| 0.002 | myelodysplastic syndrome | NA | GAD | Detail | |
| 0.002 | acquired immunodeficiency syndrome | NA | GAD | Detail | |
| <0.001 | adenocarcinoma | NA | BeFree | Detail | |
| <0.001 | aplastic anemia | NA | BeFree | Detail | |
| <0.001 | Cooley's anemia | NA | BeFree | Detail | |
| 0.080 | Anxiety Disorders | NA | RGD | Detail | |
| <0.001 | arteriosclerosis | NA | BeFree | Detail | |
| 0.003 | asthma | NA | BeFree,GAD | Detail | |
| <0.001 | atherosclerosis | NA | BeFree | Detail | |
| <0.001 | azoospermia | NA | BeFree | Detail | |
| 0.003 | beta thalassemia | NA | LHGDN | Detail | |
| 0.007 | Malignant neoplasm of urinary bladder | NA | BeFree,GAD | Detail | |
| 0.050 | Malignant neoplasm of breast | The purpose of this study was to investigate the role of single nucleotide polym... | BeFree,GAD | 25410489 | Detail |
| <0.001 | Malignant tumor of colon | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of endometrium | NA | BeFree | Detail | |
| 0.002 | Non-small cell lung carcinoma | NA | GAD | Detail | |
| 0.002 | renal cell carcinoma | NA | GAD | Detail |
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In conclusion, we have described for the first time a significant correlation of statin treatment an... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| CYP3A4*22 (c.522-191 C>T; rs35599367) is associated with lopinavir pharmacokinetics in HIV-positive ... | DisGeNET | Detail |
| CYP3A4 polymorphism and lopinavir toxicity in an HIV-infected pregnant woman. | DisGeNET | Detail |
| We evaluated EFV400 and EFV600 pharmacokinetics (NONMEM v. 7.2), assessing patient demographics and ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Polymorphism of CYP3A4 2 and eNOS genes in the diabetic patients with hyperlipidemia undergoing stat... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In the present study, the effects of artemisinin on pregnane X receptor (PXR)-mediated CYP3A express... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We genotyped eight common single-nucleotide polymorphisms (SNPs) in the CYP3A4 and CYP3A5 genes in 5... | DisGeNET | Detail |
| In interaction with gender a common CYP3A4 polymorphism may influence the survival rate of chemother... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Establishment of cytochrome P450 3A4 and glutathione S-transferase A1-transfected human hepatoma cel... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| When compared with the wild-type genotype, the variant genotypes rs5767743 and rs5767700 correlated ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Aim of this review is: (i) to describe the molecular mechanisms associated to statin induced myopath... | DisGeNET | Detail |
| No association between CYP3A4*22 and statin effectiveness in reducing the risk for myocardial infarc... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Association of CYP3A4/5 genotypes and expression with the survival of patients with neuroblastoma. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In the small intestine and colon, no changes of CYP enzymes were detected except for increased expre... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Both aripiprazole and haloperidol have been used in the treatment of schizophrenia, and are metaboli... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Phenprocoumon is an anticoagulant used for thromboembolic disorder prophylaxis metabolized mainly by... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| No effect of CYP3A4 intron 6 C>T polymorphism (CYP3A4*22) on lipid-lowering response to statins in G... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Two SNPs associated with docetaxel toxicity were identified: CYP3A4*1B with infusion-related reactio... | DisGeNET | Detail |
| Levels of enzymes that determine testosterone catabolism such as CYP3A4 have been associated with pr... | DisGeNET | Detail |
| Association between cytochrome CYP17A1, CYP3A4, and CYP3A43 polymorphisms and prostate cancer risk a... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Whole-exome sequencing reveals defective CYP3A4 variants predictive of paclitaxel dose-limiting neur... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In multivariate analyses, we observed a significantly decreased risk of breast cancer associated wit... | DisGeNET | Detail |
| In multivariate analyses, we observed a significantly decreased risk of breast cancer associated wit... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Levels of enzymes that determine testosterone catabolism such as CYP3A4 have been associated with pr... | DisGeNET | Detail |
| Association between cytochrome CYP17A1, CYP3A4, and CYP3A43 polymorphisms and prostate cancer risk a... | DisGeNET | Detail |
| Tamoxifen-associated hot flash severity is inversely correlated with endoxifen concentration and CYP... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The purpose of this study was to investigate the role of single nucleotide polymorphism in the ABCB1... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Association of CYP3A4/5 genotypes and expression with the survival of patients with neuroblastoma. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We genotyped eight common single-nucleotide polymorphisms (SNPs) in the CYP3A4 and CYP3A5 genes in 5... | DisGeNET | Detail |
| Establishment of cytochrome P450 3A4 and glutathione S-transferase A1-transfected human hepatoma cel... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The purpose of this study was to investigate the role of single nucleotide polymorphism in the ABCB1... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- dbSNP
- rs386580934 dbSNP
- Genome
- hg19
- Position
- chr7:99,354,583-99,381,871
- Variant Type
- snv
Genome browser